Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Double-blind, Placebo-controlled, Phase 2 Trial Investigating the Safety and Efficacy of C21 in Hospitalised Subjects With COVID-19 Infection Not Requiring Mechanical Ventilation

NCT04452435 is registered in ClinicalTrials.gov with Vicore Pharma AB as lead sponsor.

NCT NCT04452435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04452435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Double-blind, Placebo-controlled, Phase 2 Trial Investigating the Safety and Efficacy of C21 in Hospitalised Subjects With COVID-19 Infection Not Requiring Mechanical Ventilation
Lead sponsor
Vicore Pharma AB
Phase
Phase 2
Overall status
Completed
Start date
July 21, 2020
Completion date
October 13, 2020
Enrollment
206 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19